2026-01-26 - Analysis Report
**Company Overview:**
Planet Labs, Inc., a company focused on Earth observation and remote sensing services, operates a constellation of satellites for monitoring climate change, agriculture, and disaster response.

**1. Return Rate Comparison**
- **Review Stock (PL):** Cumulative Return = 557.65%
- **Comparison Stock (VOO):** Cumulative Return = 59.58%
- **Divergence:** 498.07% (Difference in cumulative return on the last day)
- The review stock has a significantly higher cumulative return rate compared to the S&P 500, indicating a high divergence.

**2. Recent Stock Price Fluctuations**
- **Close Price:** $26.94
- **5-day SMA:** $27.23
- **20-day SMA:** $23.62
- **60-day SMA:** $16.99
- The stock price is above both the 5-day and 20-day moving averages, but below the 60-day moving average, indicating short-term growth but long-term decline.

**3. RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**
- **Market Risk Indicator (MRI):** 0.70 (Medium Investment)
- **RSI:** 76.02 (High)
- **PPO:** -0.74 (Buy signal)
- **Recent Relative Divergence Change:** -7.00 (-) (Worsening)
- **Expected Return (%):** -9.80% (Expected excess return compared to S&P 500)
- The stock has a high RSI value, indicating overbought conditions.

**4. Recent News & Significant Events**

- [2026-01-12] Planet Labs (PL) Stock Trades Up, Here Is Why - Yahoo Finance
- [2026-01-23] Planet Labs PBC (NYSE:PL) Stock Price Up 6.3% - Time to Buy? - MarketBeat
- [2026-01-06] Why Planet Labs Stock Powered Nearly 66% Higher Last Month - The Motley Fool
- [2026-01-23] Insider Sale: Director at $PL Sells 47,835 Shares - Quiver Quantitative
- [2026-01-13] Planet Labs Inks 9-Figure Deal With Sweden, Drives PL Stock 12% Higher - TIKR.com
- [2026-01-23] Vijaya Gadde Sells 20,000 Shares of Planet Labs PBC (NYSE:PL) Stock - MarketBeat
- Recent news highlights significant stock price movements and a notable deal with Sweden.

**4-2. Analyst Opinions**
- **Analyst Consensus:**
- **Key:** Buy
- **Mean (Buy/Sell):** 1.70 (Buy)
- **Opinions:** 9
- **Target Price (avg/high/low):** $24.16 / $30.00 / $16.40
- Analysts have a consensus of Buy with a moderate target price.

**5. Recent Earnings Analysis**
| **Date** | **EPS** | **Revenue** |
| --- | ---: | ---: |
| 2025-10-28 | 0.82 | $2.21 B |
| 2025-07-30 | 0.61 | $2.18 B |
| 2025-04-29 | 0.64 | $2.14 B |
| 2025-02-14 | 1.38 | $2.20 B |
| 2024-10-25 | 1.08 | $2.04 B |
- The company has reported significant revenue growth but decreasing EPS.

**6. Financial Information**
| **Quarter** | **Revenue** | **Profit Margin** |
| --------- | ---------- | --------------- |
| 2025-10-31 | $0.08B | 57.33% |
| 2025-07-31 | $0.07B | 57.60% |
| 2025-04-30 | $0.07B | 55.24% |
| 2025-01-31 | $0.06B | 62.08% |
| 2024-10-31 | $0.06B | 61.24% |

| **Quarter** | **Equity** | **ROE** |
| --------- | --------- | ----- |
| 2025-10-31 | $0.35B | -16.93% |
| 2025-07-31 | $0.44B | -5.19% |
| 2025-04-30 | $0.44B | -2.84% |
| 2025-01-31 | $0.44B | -7.97% |
| 2024-10-31 | $0.46B | -4.32% |

- The company has reported a high profit margin and equity but negative ROE in most quarters.

**7. Comprehensive Analysis**
The review stock has a high cumulative return rate and a positive recent performance, as indicated by the short-term growth. However, the long-term decline and negative ROE raise concerns.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.